Compounds > furazolidone

furazolidone and bismuth

furazolidone has been researched along with bismuth in 32 studies

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19902 (6.25)18.7374
1990's2 (6.25)18.2507
2000's5 (15.63)29.6817
2010's11 (34.38)24.3611
2020's12 (37.50)2.80

Authors

AuthorsStudies
Dickgiesser, N; Kasper, G1
Turner, AC1
Angel, A; Genta, RM; Graham, DY; Gutiérrez, O; Otero, W; Segura, AM1
Carrazco, J; Checkley, W; Cordero, L; Gilman, RH; Leon-Barua, R; McDonald, J; Ramirez-Ramos, A; Recavarren-Arce, S; Salazar, G; Valdez, Y; Watanabe, J1
Fang, XC; Hu, PJ; Li, ZS; Lu, H; Lu, XH; Xiao, SD; Zhang, DZ1
Ammon, S; Klotz, U; Malfertheiner, P; Treiber, G1
Candelli, M; Carloni, E; Cazzato, A; Di Campli, C; Fini, L; Gasbarrini, A; Gasbarrini, G; Nista, EC; Pignataro, G; Zocco, MA1
Buzás, GM; Józan, J1
Cheng, H; Hu, FL1
Ghadir, MR; Iranikhah, A; Joukar, F; Mansour-Ghanaei, F; Pakdin, A; Shafaghi, A1
Gao, W; Hu, FL; Wang, XM1
Bari, Z; Fakheri, H; Hosseini, V; Taghvaei, T1
Bari, Z; Fakheri, H; Sardarian, H1
Cheng, H; Gao, W; Hu, F; Zhang, X; Zhang, Y1
Hu, Y; Lu, NH; Zhu, Y1
Attaran, B; Graham, DY; Malekzadeh, R; Mohammadi, M1
Chen, L; Chen, S; Chen, X; Chen, Y; Chu, H; Deng, Y; Ge, Q; He, H; He, J; Li, A; Long, Y; Wang, L1
Cai, T; Tang, D; Wang, F; Yao, Y; Yuan, L; Yue, C1
Cai, Y; Dai, N; Du, Q; Hu, WL; Kao, JY; Kim, JJ; Si, JM; Zhang, YW; Zheng, WF1
Campos Rubio, JC; de Carvalho, DÉL; Faria, PE; Silva, KMMN; Silva-Caldeira, PP; Valente, VMM1
Jin, Z; Li, Y; Lin, D; Lin, L; Meng, F; Pan, J; Shi, Z; Wu, J; Yang, N; Zhang, J; Zhou, Q1
Chen, J; Chen, Q; Fang, HM; Huang, YT; Kan, LD; Li, LC; Qiu, Y; Yu, XL1
Hu, JN; Ji, CR; Ji, R; Li, LX; Li, YQ; Li, YY; Lin, MJ; Liu, J; Qiao, C; Qu, JY; Zuo, XL1
Hu, J; Ji, C; Ji, R; Li, Y; Lin, B; Lin, M; Liu, J; Qi, Q; Qiao, C; Qu, J; Wan, M; Zuo, X1
Chen, H; Huang, K; Jin, D; Kong, S; Ye, F; Zhang, G1
Hu, JN; Ji, CR; Li, LX; Li, YY; Lin, BS; Lin, MJ; Liu, J; Qiao, C; Wan, M; Wang, J; Zha, J; Zuo, XL1
Cao, Y; He, W; Li, X; Wang, J1
Bi, H; Chen, X; Chen, Y; Han, S; Li, M; Lin, T; Liu, J; Lyu, T; Shi, Y; Wang, J; Wang, S; Yuan, D; Zhao, X1
Du, Q; Han, Y; Li, Y; Lou, G; Lu, L; Wang, Y; Yan, H; Ye, J1
Huang, J; Lin, Y1
Du, Q; Li, Y; Liao, O; Liu, X; Lou, G; Wang, Y; Wu, H; Wu, Y; Ye, J1
Bai, FH; Chen, C; Chen, RX; Chen, SJ; Huang, SM; Li, D; Zeng, F; Zhang, DY; Zhang, XD1

Reviews

4 review(s) available for furazolidone and bismuth

ArticleYear
Treatment of H. pylori infection: a review.
    Current medicinal chemistry, 2005, Volume: 12, Issue:4

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bismuth; Clarithromycin; Fluoroquinolones; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Ofloxacin; Polypharmacy; Ranitidine; Rifabutin

2005
Nitrofuran-based regimens for the eradication of Helicobacter pylori infection.
    Journal of gastroenterology and hepatology, 2007, Volume: 22, Issue:10

    Topics: Anti-Infective Agents, Local; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Proton Pump Inhibitors; Ranitidine

2007
Novel and Effective Therapeutic Regimens for
    Frontiers in cellular and infection microbiology, 2017, Volume: 7

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Mutation; Prevalence; Probiotics; Proton Pump Inhibitors; Pyrroles; Rifabutin; Sulfonamides; Tetracycline; Tetracycline Resistance

2017
Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran.
    Digestive diseases and sciences, 2017, Volume: 62, Issue:8

    Topics: Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Iran; Treatment Outcome

2017

Trials

18 trial(s) available for furazolidone and bismuth

ArticleYear
Travellers' diarrhoea: prevention by chemoprophylaxis.
    Scandinavian journal of gastroenterology. Supplement, 1983, Volume: 84

    Topics: Adult; Bismuth; Clioquinol; Diarrhea; Drug Combinations; Drug Therapy, Combination; Furazolidone; Humans; Neomycin; Organometallic Compounds; Salicylates; Streptomycin; Sulfadiazine; Sulfamethazine; Sulfathiazoles; Travel

1983
Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Gastrointestinal Physiology Working Group of the Universidad Peruana Cayetano Heredia and The Johns Hopkins University.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:5

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peru; Recurrence; Salicylates; Tetracycline; Tinidazole

1997
One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:12

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Bismuth; Diarrhea; Dizziness; Double-Blind Method; Drug Therapy, Combination; Exanthema; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Prospective Studies; Pruritus; Ranitidine; Tetracycline; Treatment Outcome; Vomiting

2001
Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures.
    Helicobacter, 2002, Volume: 7, Issue:4

    Topics: Anti-Bacterial Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Proton Pumps; Treatment Failure; Treatment Outcome

2002
Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori.
    World journal of gastroenterology, 2009, Feb-21, Volume: 15, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole; Treatment Outcome; Young Adult

2009
Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2011, Volume: 22, Issue:1

    Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer; Treatment Outcome

2011
[Effect of furazolidone quadruple regimen plus dental plaque removal procedures as rescue treatment of refractory Helicobacter pylori infection].
    Zhonghua yi xue za zhi, 2011, Mar-29, Volume: 91, Issue:12

    Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dental Plaque; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Treatment Failure; Young Adult

2011
A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.
    Helicobacter, 2012, Volume: 17, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Middle Aged; Organometallic Compounds; Pantoprazole

2012
A modified bismuth-containing quadruple therapy including a short course of furazolidone for Helicobacter pylori eradication after sequential therapy failure.
    Helicobacter, 2012, Volume: 17, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Treatment Failure; Treatment Outcome; Young Adult

2012
Efficacies of different proton pump inhibitor-based 14-day bismuth-furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China: an open-label, randomized clinical trial.
    Clinical and experimental medicine, 2018, Volume: 18, Issue:4

    Topics: Adult; Amoxicillin; Bismuth; Breath Tests; China; Drug Administration Schedule; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome

2018
Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trial.
    Frontiers of medicine, 2020, Volume: 14, Issue:1

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; China; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome

2020
Susceptibility-guided quadruple therapy is not superior to medication history-guided therapy for the rescue treatment of Helicobacter pylori infection: A randomized controlled trial.
    Journal of digestive diseases, 2020, Volume: 21, Issue:10

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Treatment Outcome

2020
Clarithromycin versus furazolidone for naïve Helicobacter pylori infected patients in a high clarithromycin resistance area.
    Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:9

    Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Treatment Outcome

2021
Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori.
    Medicine, 2021, Dec-23, Volume: 100, Issue:51

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Tetracycline; Treatment Outcome

2021
Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial.
    Chinese medical journal, 2022, Jul-20, Volume: 135, Issue:14

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Esomeprazole; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Potassium Citrate; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Treatment Outcome

2022
Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trial.
    Helicobacter, 2023, Volume: 28, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Esomeprazole; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Treatment Outcome

2023
Efficacy of quadruple therapy with clarithromycin based on faecal molecular antimicrobial susceptibility tests as first-line treatment for
    BMJ open, 2023, 07-21, Volume: 13, Issue:7

    Topics: Amoxicillin; Anti-Infective Agents; Bismuth; China; Clarithromycin; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Rabeprazole; Randomized Controlled Trials as Topic; Single-Blind Method

2023
Ilaprazole-amoxicillin dual therapy at high dose as a first-line treatment for helicobacter pylori infection in Hainan: a single-center, open-label, noninferiority, randomized controlled trial.
    BMC gastroenterology, 2023, Jul-24, Volume: 23, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Bismuth; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans

2023

Other Studies

10 other study(ies) available for furazolidone and bismuth

ArticleYear
[Clinical significance, epidemiology and laboratory diagnosis of Campylobacter pyloridis].
    Immunitat und Infektion, 1986, Volume: 14, Issue:2

    Topics: Amoxicillin; Antibodies, Bacterial; Biopsy; Bismuth; Campylobacter; Campylobacter Infections; Chronic Disease; Furazolidone; Gastric Mucosa; Gastritis; Humans; Organometallic Compounds; Tinidazole; Urease

1986
Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:3

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged

1997
Tetracycline- and furazolidone-containing quadruple regimen as rescue treatment for Helicobacter pylori infection: a single center retrospective study.
    Helicobacter, 2014, Volume: 19, Issue:5

    Topics: Adult; Aged; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole; Retrospective Studies; Tetracycline; Treatment Outcome; Young Adult

2014
[Efficacy of bismuth containing quadruple therapies on Helicobacter pylori eradication in patients with history of antibiotic treatment].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2018, Jul-28, Volume: 43, Issue:7

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tinidazole; Treatment Outcome

2018
Outcomes of furazolidone- and amoxicillin-based quadruple therapy for
    World journal of gastroenterology, 2018, Oct-28, Volume: 24, Issue:40

    Topics: Adult; Alcohol Drinking; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bismuth; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Patient Education as Topic; Proton Pump Inhibitors; Treatment Failure

2018
Concomitant and controlled release of furazolidone and bismuth(III) incorporated in a cross-linked sodium alginate-carboxymethyl cellulose hydrogel.
    International journal of biological macromolecules, 2019, Apr-01, Volume: 126

    Topics: Alginates; Anti-Bacterial Agents; Bismuth; Calorimetry, Differential Scanning; Carboxymethylcellulose Sodium; Cross-Linking Reagents; Delayed-Action Preparations; Drug Liberation; Escherichia coli; Furazolidone; Hydrogels; Microbial Sensitivity Tests; Spectroscopy, Fourier Transform Infrared; Water; X-Ray Diffraction

2019
Evaluation of different proton pump inhibitors combined with bismuth quadruple regimens in Helicobacter pylori eradication.
    Clinical and experimental medicine, 2020, Volume: 20, Issue:4

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; China; Drug Costs; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Humans; Male; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome

2020
Antibiotic susceptibility guided reuse of levofloxacin-based therapy in a penicillin-allergic patient for Helicobacter pylori infection: A case report.
    Medicine, 2021, Mar-12, Volume: 100, Issue:10

    Topics: Anti-Bacterial Agents; Bismuth; DNA, Bacterial; Drug Hypersensitivity; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Furazolidone; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Middle Aged; Penicillins; Recurrence; Retreatment; Treatment Outcome

2021
Two Different 1-Week Quadruple Therapies Given Back-to-Back Consecutive Therapy for Difficult-to-Treat Helicobacter pylori Infection: A Pilot Study.
    Clinical and translational gastroenterology, 2021, 08-16, Volume: 12, Issue:8

    Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Tetracycline; Treatment Outcome

2021
Vonoprazan on the Eradication of Helicobacter pylori Infection.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2023, Volume: 34, Issue:3

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Potassium Citrate; Proton Pump Inhibitors; Treatment Outcome

2023